Entities / Company
Amorfix (Canada).
company in Mississauga, Canada
- Reports this week
- 0
- Active events
- 0
- Connections
- 17
What's happening
Gone quiet
No new reports in 90+ days-
Director of Amorfix purchased shares on July 11, 2025.Some support1 report
-
FDA granted Fast Track designation to Amorfix for its antibody therapeutic targeting Alzheimer's Disease.Some support5 reports
-
Amorfix received FDA Fast Track designation in Cambridge, MA.Some support1 report1 development inside
-
Amorfix announced financing on July 28, 2025, from locations including Cambridge, MA and Toronto, Ontario.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Amorfix (Canada) this week
News at the entities that move Amorfix (Canada) most-
FDA StructuralAtriCure, Inc. reported revenue via NASDAQ and received FDA 510(k) clearance for its device.Moves Amorfix (Canada)
-
Toronto Shared contextOlivia Chow and Doug Ford negotiated a historic financial agreement to guide Toronto through current financial and policy challenges.Moves Amorfix (Canada)
-
Cambridge Shared contextAn event featuring historical scientific instruments was held in Cambridge, MA, involving professor Evelynn Hammonds.Moves Amorfix (Canada)
Connections
The 3 strongest of 17, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA granted Fast Track designation to Amorfix's product, indicating formal regulatory oversight.
-
Toronto Shared context
Amorfix operates and conducts financing activities within the geographical context of Toronto.
-
Cambridge Shared context
The company is located in or conducts business activities from Cambridge, Massachusetts.
History
Events by the month they beganJune 2026
4 events- Director of Amorfix purchased shares on July 11, 2025.
- FDA granted Fast Track designation to Amorfix for its antibody therapeutic targeting Alzheimer's Disease.
- Amorfix received FDA Fast Track designation in Cambridge, MA.
- Amorfix announced financing on July 28, 2025, from locations including Cambridge, MA and Toronto, Ontario.